VISEN Pharmaceuticals Share Price
Stocks
2561
KYG93Y5D1039
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
09:08:09 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 18.50 HKD | -1.18% |
|
-2.32% | -43.60% |
| 09-21 | VISEN Pharmaceuticals(SEHK:2561) dropped from S&P Global BMI Index | CI |
| 08-27 | VISEN Pharmaceuticals Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 1.73B 2.02B 258M 229M 214M 195M 367M 24.77B 371M 2.59B 1B 12.66B 967M 946M 40.64B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.47B 1.71B 219M 194M 181M 165M 312M 21.01B 314M 2.19B 850M 10.74B 821M 803M 34.47B | EV / Sales 2026 * |
21.6x | EV / Sales 2027 * | 5.4x |
| Free-Float |
28.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Hong Kong S.E.HKD
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2561 | Delayed | |
Tradegate
| T06 | Real-time | |
|
Deutsche Boerse AG
| T06 | Delayed |
| 1 day | -1.18% | ||
| 1 week | -2.32% | ||
| Current month | -1.18% | ||
| 1 month | -3.75% | ||
| 3 months | -29.98% | ||
| 6 months | -25.34% | ||
| Current year | -43.60% |
| 1 week | 18.5 |  | 19.2 |
| 1 month | 18.5 | | 20.18 |
| Current year | 18.5 | | 43.3 |
| 1 year | 18.5 | | 45 |
| 3 years | 18.5 | | 69.15 |
| 5 years | 18.5 | | 69.15 |
| 10 years | 18.5 | | 69.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
An Bang Lu
CEO | Chief Executive Officer | 60 | 06/11/2018 |
Ying Lu
DFI | Director of Finance/CFO | 42 | 12/10/2025 |
Jun Yang
CTO | Chief Tech/Sci/R&D Officer | 54 | 31/03/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
An Bang Lu
BRD | Director/Board Member | 60 | 06/11/2018 |
Yi Bo Cao
BRD | Director/Board Member | 44 | 07/01/2021 |
Peng Kuan Chan
BRD | Director/Board Member | 62 | 31/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/01/26 | Other | Chief Executive Officer | 108,750 | 0.0955% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.18% | -2.32% | -57.43% | - | 258M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | -0.32% | -0.76% | +41.63% | +128.54% | 39.08B | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.88% | +138.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.73M 79.27M 10.1M 8.98M 8.38M 7.64M 14.4M 971M 14.54M 101M 39.29M 496M 37.93M 37.11M 1.59B | 320M 374M 47.7M 42.38M 39.56M 36.05M 68M 4.59B 68.63M 479M 185M 2.34B 179M 175M 7.52B |
| Net income | - | - |
| Net Debt | -262M -307M -39.12M -34.76M -32.44M -29.57M -55.77M -3.76B -56.29M -393M -152M -1.92B -147M -144M -6.17B | 486K 569K 72.5K 64.41K 60.12K 54.8K 103K 6.97M 104K 728K 282K 3.56M 272K 266K 11.43M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | HK$18.50 | -1.18% | 2,600 |
| 30/09/26 | HK$18.72 | +1.08% | 4,900 |
| 29/09/26 | HK$18.52 | -2.53% | 5,600 |
| 28/09/26 | HK$19.00 | +0.32% | 6,500 |
| 25/09/26 | HK$18.94 | +0.32% | 2,100 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
15.81CNY
Average target price
42.85CNY
Spread / Average Target
+171.08%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2561 Stock
Select your edition
All financial news and data tailored to specific country editions
